GREENWAY MEDICAL TECHNOLOGIES INC Research and Development Expense
GREENWAY MEDICAL TECHNOLOGIES INC reported Research and Development Expense of $4.54 million for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2013-11-12
- GREENWAY MEDICAL TECHNOLOGIES INC research and development expense for the quarter ending 2013-09-30 was $4.54M, a 4.97% decline year-over-year.
- GREENWAY MEDICAL TECHNOLOGIES INC research and development expense for the quarter ending 2013-06-30 was $5.19M, a 11.25% increase year-over-year.
- GREENWAY MEDICAL TECHNOLOGIES INC research and development expense for the quarter ending 2013-03-31 was $4.55M, a 13.28% increase year-over-year.
- GREENWAY MEDICAL TECHNOLOGIES INC research and development expense for the quarter ending 2012-12-31 was $4.44M, a 15.50% increase year-over-year.
- GREENWAY MEDICAL TECHNOLOGIES INC research and development expense for fiscal 2013 was $18.96M, a 20.79% increase from fiscal 2012.
- GREENWAY MEDICAL TECHNOLOGIES INC research and development expense for fiscal 2012 was $15.70M, a 91.00% increase from fiscal 2011.
- GREENWAY MEDICAL TECHNOLOGIES INC research and development expense for fiscal 2011 was $8.22M, a 37.17% increase from fiscal 2010.
- GREENWAY MEDICAL TECHNOLOGIES INC research and development expense for fiscal 2010 was $5.99M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2013-09-30 | $4.54M 10-Q · filed 2013-11-12 | $9.73M derived: sum of 2 quarters · filed 2013-11-12 | $14.28M derived: sum of 3 quarters · filed 2013-11-12 | $18.72M derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-06-30 | $5.19M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-13 | $9.75M derived: sum of 2 quarters · filed 2013-09-13 | $14.19M derived: sum of 3 quarters · filed 2013-09-13 | $18.96M 10-K · filed 2013-09-13 |
| 2013-03-31 | $4.55M 10-Q · filed 2013-05-09 | $8.99M derived: sum of 2 quarters · filed 2013-05-09 | $13.77M 10-Q · filed 2013-05-09 | $18.43M derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-12-31 | $4.44M 10-Q · filed 2013-02-14 | $9.21M 10-Q · filed 2013-02-14 | $13.88M derived: sum of 3 quarters · filed 2013-11-12 | $17.90M derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-09-30 | $4.77M 10-Q · filed 2013-11-12 | $9.44M derived: sum of 2 quarters · filed 2013-11-12 | $13.46M derived: sum of 3 quarters · filed 2013-11-12 | $17.30M derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | $4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-13 | $8.69M derived: sum of 2 quarters · filed 2013-09-13 | $12.53M derived: sum of 3 quarters · filed 2013-09-13 | $15.70M 10-K · filed 2013-09-13 |
| 2012-03-31 | $4.02M 10-Q · filed 2013-05-09 | $7.87M derived: sum of 2 quarters · filed 2013-05-09 | $11.03M 10-Q · filed 2013-05-09 | $13.62M derived: sum of 4 quarters · filed 2013-09-13 |
| 2011-12-31 | $3.84M 10-Q · filed 2013-02-14 | $7.01M 10-Q · filed 2013-02-14 | $9.60M derived: sum of 3 quarters · filed 2013-09-13 | $11.88M derived: sum of 4 quarters · filed 2013-09-13 |
| 2011-09-30 | $3.17M 10-Q · filed 2012-11-13 | $5.75M derived: sum of 2 quarters · filed 2013-09-13 | $8.04M derived: sum of 3 quarters · filed 2013-09-13 | $9.56M derived: sum of 4 quarters · filed 2013-09-13 |
| 2011-06-30 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-13 | $4.88M derived: sum of 2 quarters · filed 2013-09-13 | $6.39M derived: sum of 3 quarters · filed 2013-09-13 | $8.22M 10-K · filed 2013-09-13 |
| 2011-03-31 | $2.29M 10-Q · filed 2012-05-10 | $3.80M derived: sum of 2 quarters · filed 2012-05-10 | $5.63M 10-Q · filed 2012-05-10 | |
| 2010-12-31 | $1.52M 10-Q · filed 2012-03-14 | $3.34M 10-Q · filed 2012-03-14 | ||
| 2010-06-30 | $5.99M 10-K · filed 2012-09-21 |